Michael Raab insider trades
Open-market stock purchases and sales by Michael Raab, President & CEO at Ardelyx, Inc, from SEC Form 4 filings since Jun 15, 2010.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 21, 2026 | ARDX Ardelyx, Inc | Sold | $57.9K |
| Aug 21, 2026 | ARDX Ardelyx, Inc | Sold | $61.6K |
| Aug 21, 2026 | ARDX Ardelyx, Inc | Sold | $32.4K |
| Aug 21, 2026 | ARDX Ardelyx, Inc | Sold | $74K |
| Jul 15, 2026 | ARDX Ardelyx, Inc | Sold | $211K |
| Jul 15, 2026 | ARDX Ardelyx, Inc | Bought (not open market) | — |
| Jun 15, 2026 | ARDX Ardelyx, Inc | Sold | $236K |
| Jun 15, 2026 | ARDX Ardelyx, Inc | Bought (not open market) | — |
| May 21, 2026 | ARDX Ardelyx, Inc | Sold | $93.6K |
| May 21, 2026 | ARDX Ardelyx, Inc | Sold | $49.3K |
| May 21, 2026 | ARDX Ardelyx, Inc | Sold | $112K |
| May 21, 2026 | ARDX Ardelyx, Inc | Sold | $87.9K |
| May 15, 2026 | ARDX Ardelyx, Inc | Bought (not open market) | — |
| May 15, 2026 | ARDX Ardelyx, Inc | Sold | $262K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $1.7M |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $134K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $140K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $234K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $238K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $387K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $388K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $385K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $436K |
| Apr 27, 2026 | FOLD Amicus Therapeutics, Inc | Sold (not open market) | $446K |
| Apr 15, 2026 | ARDX Ardelyx, Inc | Sold | $262K |